Kinfo
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc.

LFCRNASDAQHealthcare·US · USD
$4.96
-0.21 (-4.06%)
Close · 2026-06-29

Price

Key statistics

Valuation
Market cap193.92M USD
Enterprise value372.49M USD
Trailing P/E56.23
Forward P/E-6.38
PEG ratio0.78
Price / sales1.50
Price / book-6.69
Profitability
Gross margin19.24%
Operating margin-13.25%
Profit margin-23.78%
Return on assets-19.11%
Return on equity312.34%
Income (TTM)
Revenue129.46M USD
Gross profit40.61M USD
EBITDA8.24M USD
Net income-34.50M USD
Diluted EPS-$1.27
Rev. growth (YoY)-25.45%
Balance sheet
Total cash20.80M USD
Total debt150.14M USD
Debt / equity722.60
Current ratio3.49
Book value / share-$0.38
Cash flow (TTM)
Operating cash flow12.57M USD
Levered free cash flow163.59M USD
Shares & price
Shares outstanding37.48M
Float19.43M
Held by institutions77.19%
Beta1.07
50-day MA$5.14
200-day MA$6.55
52-week high$8.98
52-week low$3.63
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-06-0.30-0.43−43.33%2026-04-080.350.57+62.86%2026-03-16-0.16-0.16+0.00%2025-11-06-0.30-0.43−43.33%2025-08-07-0.09-0.06+33.33%
About Lifecore Biomedical, Inc.

Lifecore Biomedical Inc. is a prominent entity in the biotechnology sector, primarily engaged in the manufacture and development of high-quality biomedical products. The company specializes in the production of hyaluronan and other polysaccharide-based products for medical applications. These biomaterials are crucial in various medical fields, including ophthalmology, orthopedics, and general surgery, thanks to their biocompatibility and multifunctional characteristics. Lifecore Biomedical Inc.'s expertise in manufacturing and formulation is underscored by its integration with the pharmaceutical and health industries, where its products are utilized in drug delivery systems and surgical applications. Established with a commitment to quality and innovation, the company plays a significant role in advancing medical technology and improving patient outcomes globally. Its presence in the market underscores the critical interface between leading-edge biotechnology and practical health applications, making it a key player in the advancement of medical treatments and technologies.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Paul Josephs
Employees
382
Headquarters
Chaska, MN, United States

Frequently asked questions about Lifecore Biomedical, Inc.